Has Sridhar Jatla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,054 in general payments to Sridhar Jatla, MD across 624 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sridhar Jatla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sridhar Jatla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sridhar Jatla, MD

Sleep Medicine · Kokomo, INNPI 1891704565

Payments from drug & device makers

$10,054in general payments, 2019–2025

Across 624 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Harmony Biosciences LLC$2K
Jazz Pharmaceuticals Inc.$1K
Avadel CNS Pharmaceuticals, LLC$852
Teva Pharmaceuticals USA, Inc.$636
AbbVie$520
Axsome Therapeutics, Inc.$490
plus $4K from 53 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Harmony Biosciences LLC	95	$1,653
Jazz Pharmaceuticals Inc.	84	$1,431
Avadel CNS Pharmaceuticals, LLC	32	$852
Teva Pharmaceuticals USA, Inc.	40	$636
AbbVie(2 entities)	37	$520
Axsome Therapeutics, Inc.	34	$490
Lilly USA, LLC	24	$402
Merck	22	$385
Vanda Pharmaceuticals Inc.	17	$385
Eisai Inc.	20	$316
Neurocrine Biosciences, Inc.	15	$266
UCB, Inc.	14	$253
Supernus Pharmaceuticals, Inc.	67	$249
Idorsia Pharmaceuticals US Inc	14	$190
Amgen(2 entities)	10	$166
Acadia Pharmaceuticals Inc	9	$160
AstraZeneca	3	$157
Argenx US, Inc.	7	$126
Resmed Corp	6	$98
Ironshore Pharmaceuticals Inc.	5	$93
Sanofi	4	$85
Arbor Pharmaceuticals, Inc.	5	$71
Biogen	3	$67
Johnson & Johnson	3	$62
Acorda Therapeutics, Inc	3	$59
Upsher-smith Laboratories LLC	3	$51
Banner Life Sciences, LLC	2	$49
PTC Therapeutics, Inc.	2	$48
Fisher & Paykel Healthcare Inc	3	$45
Itamar Medical Inc	2	$44
Tanabe Pharma America, Inc.	2	$42
Sunovion Pharmaceuticals Inc.	4	$41
Novartis	2	$38
Inspire Medical Systems, Inc.	2	$36
TG Therapeutics, Inc.	2	$35
Sumitomo Pharma America, Inc.	2	$32
Livanova USA, Inc.	2	$27
Biohaven Pharmaceuticals, Inc.	2	$26
Bausch Health US, LLC	1	$25
Corium, LLC	1	$22
Octapharma USA, Inc.	1	$22
Neurelis, Inc.	1	$22
Catalyst Pharmaceuticals, Inc.	1	$22
Philips North America LLC	1	$19
Springworks Therapeutics, Inc.	1	$19
Aquestive Therapeutics, Inc.	1	$19
SK Life Science, Inc.	1	$19
Grifols USA, LLC	1	$17
Merz North America, Inc.	1	$17
Medtronic	1	$16
Amneal Pharmaceuticals LLC	1	$16
CSL Behring	1	$16
Bristol Myers Squibb	1	$15
Saol Therapeutics Inc.	1	$15
Azurity Pharmaceuticals, Inc.	1	$14
Genentech USA, Inc.	1	$13
EMD Serono, Inc.	1	$13
Greenwich Biosciences, Inc.	1	$13
Avanir Pharmaceuticals, Inc.	1	$11

How this compares

$10,054 in reported general payments places this provider in the 85th percentile of 32 sleep medicine providers in Indiana.

See all sleep medicine providers in Indiana →

Medicare billing

Part B allowed, 2024

$127,367

Medicare patients

750

Services billed

1,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sleep medicine in Kokomo

Shalini ManchandaIndianapolis$327K
Douglas LiepertSouth Bend$37K
Ninotchka SiguaIndianapolis$35K
Aaron RobertsFort Wayne$31K
Israr SiddiqiElkhart$8K
Adam LenetIndianapolis$5K
Alaa ShammahIndianapolis$3K
Akudo AnokwuteBrownsburg$3K
Joshua BowlingMishawaka$3K
Ram VermaFort Wayne$3K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →